Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Singapore Institute of Advanced Medicine Holdings Ltd. reported a 3% increase in revenue to $16.65 million for the year ending June 2024, with a significant boost in their Radiation Therapy and Medical Oncology Services segment. The company’s innovative use of the Varian ProBeam Compact proton therapy system, operational since June 2023, is seen as a key driver of this growth. Despite a loss of $37.4 million, the firm remains at the forefront of cutting-edge cancer treatment technologies.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ‘Looking Good for 2025,’ Says Investor About Nio Stock
- ‘The Bull Run Isn’t Over,’ Says Top Investor About Palantir Stock
- ‘There’s Hope for the Hopeless,’ Says Investor About Intel Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
